Clinical Trial to Reduce Perinatal Intimate Partner Violence
University of Pittsburgh · with National Institute of Nursing Research (NINR) · NCT07165860
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 250
- US sites recruiting
- 2
- Study start
- November 1, 2025
- Record last updated
- April 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors
Being studied: Doulas; Thrive
Conditions: Domestic Violence; Perinatal Problems
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria: Perinatal IPV survivors are eligible if they:
- 1) feel comfortable completing the study in Spanish or English
- 2) are age 18 or older
- 3) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window)
- 4) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV
- 5) live within a 50 mile radius of Pittsburgh, Pennsylvania
- 6) able to provide safe and complete contact information or take a study cell phone
Exclusion Criteria
- Unable to consent
- Do not meet inclusion criteria
- Cannot provide safe contact information or take a study cell phone
- Incarcerated
Recruiting US locations
The Midwife Center
Pittsburgh, PA 15222
Site contact: Emily McGahey · (412) 321-6880 · e.mcgahey@midwifecenter.org
Family Medicine Department
Pittsburgh, PA 15260
Site contact: Stacy Bartlett · 412-383-2377 · bartlettsj2@upmc.edu
Study contacts (from the official record)
- Maya Ragavan · 4126926545 · ragavanm@chp.edu
- Maya Ragavan · 16506449954 · ragavanm@chp.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only